RxDoctor Payments Data

Fizza Hussain, MD

Advanced Heart Failure and Transplant Cardiology · McHenry, ILNPI 1740644814

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (37.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. Abbott accounts for 83.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,086 and has fallen 78.5% since, to $234 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in IL, where the typical reported total is $11,038.

$1,683in general payments, 2019–2025

Across 26 payments — averaging $64.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Abiomed$121
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$43
  • E.r. Squibb & Sons, L.L.C.$41
  • Novartis$34
  • AstraZeneca$23
  • plus $19 from 1 others

What the payments were for

  • Travel & lodging$55433%
  • Food & beverage$63738%
  • Education$49329%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,683 in reported general payments places this provider in the 10th percentile of 56 advanced heart failure and transplant cardiology providers in Illinois.

See all advanced heart failure and transplant cardiology providers in Illinois

Medicare billing

Part B allowed, 2024
$40,133
Medicare patients
109
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin11$8,345
Losartan Potassium14$156

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in McHenry

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →